{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:15:54Z","timestamp":1764936954735,"version":"3.37.3"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671915"],"award-info":[{"award-number":["81671915"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key R&D Project","award":["2016YFC1100300"],"award-info":[{"award-number":["2016YFC1100300"]}]},{"name":"Zhongshan Hospital","award":["2016ZSQN61"],"award-info":[{"award-number":["2016ZSQN61"]}]},{"name":"Research & Development Grant of Zhongshan Hospital","award":["2017ZSKY143"],"award-info":[{"award-number":["2017ZSKY143"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bbrc.2017.12.145","type":"journal-article","created":{"date-parts":[[2017,12,24]],"date-time":"2017-12-24T02:37:02Z","timestamp":1514083022000},"page":"2630-2636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["HDAC6 interacts with PTPN1 to enhance melanoma cells progression"],"prefix":"10.1016","volume":"495","author":[{"given":"Jiaqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuedong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazhi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.12.145_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.bbrc.2017.12.145_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2017.12.145_bib3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbrc.2016.05.133","article-title":"MiR-211 is epigenetically regulated by DNMT1 mediated methylation and inhibits EMT of melanoma cells by targeting RAB22A","volume":"476","author":"Yu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.12.145_bib4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbrc.2017.03.138","article-title":"Melanoma growth and lymph node metastasis is independent of host CD169 expression","volume":"486","author":"Muhsin-Sharafaldine","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7494","key":"10.1016\/j.bbrc.2017.12.145_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","volume":"508","author":"Sun","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2017.12.145_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2017.05.008","article-title":"Chromatin accessibility landscape of cutaneous T cell lymphoma and dynamic response to HDAC inhibitors","volume":"32","author":"Qu","year":"2017","journal-title":"Canc. Cell"},{"key":"10.1016\/j.bbrc.2017.12.145_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.21037\/atm.2016.07.22","article-title":"Histone deacetylase inhibitors as cancer therapeutics","volume":"4","author":"Clawson","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbrc.2017.12.145_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbrc.2017.12.145_bib9","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1021\/jm301098e","article-title":"Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth","volume":"55","author":"Bergman","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.bbrc.2017.12.145_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121247","article-title":"An GL and He L. Down-regulation of deacetylase HDAC6 inhibits the melanoma cell line A375.S2 growth through ROS-dependent mitochondrial pathway","volume":"10","author":"Bai","year":"2015","journal-title":"PLos One"},{"key":"10.1016\/j.bbrc.2017.12.145_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12967-015-0753-0","article-title":"Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells","volume":"14","author":"Liu","year":"2016","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.bbrc.2017.12.145_bib12","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1128\/MCB.00393-07","article-title":"Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis","volume":"27","author":"Gao","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2017.12.145_bib13","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/PRS.0b013e3181a073eb","article-title":"Endothelial cell culture of intramuscular venous malformation and its invasive behavior related to matrix metalloproteinase-9","volume":"123","author":"Wang","year":"2009","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.bbrc.2017.12.145_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat Rev Cancer."},{"key":"10.1016\/j.bbrc.2017.12.145_bib15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2017.12.145_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2017.12.145_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2217\/epi.14.69","article-title":"Histone deacetylase 6 in health and disease","volume":"7","author":"Seidel","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.bbrc.2017.12.145_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tips.2014.08.001","article-title":"Drugging the HDAC6-HSP90 interplay in malignant cells","volume":"35","author":"Kramer","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2017.12.145_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/febs.12079","article-title":"Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes","volume":"280","author":"Li","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2017.12.145_bib20","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1158\/0008-5472.CAN-07-5989","article-title":"Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation","volume":"68","author":"Rodriguez-Gonzalez","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2017.12.145_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ncb3376","article-title":"PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia","volume":"18","author":"Banh","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2017.12.145_bib22","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0002-9378(94)70118-0","article-title":"Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas","volume":"170","author":"Wiener","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbrc.2017.12.145_bib23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.canlet.2015.01.020","article-title":"PTP1B promotes cell proliferation and metastasis through activating src and ERK1\/2 in non-small cell lung cancer","volume":"359","author":"Liu","year":"2015","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2017.12.145_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/exmp.2000.2303","article-title":"Expression of protein tyrosine phosphatases and its significance in esophageal cancer","volume":"68","author":"Warabi","year":"2000","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbrc.2017.12.145_bib25","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.1158\/0008-5472.CAN-05-1353","article-title":"Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development","volume":"65","author":"Dube","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2017.12.145_bib26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/15384101.2014.998047","article-title":"Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients","volume":"14","author":"Wang","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2017.12.145_bib27","first-page":"1531","article-title":"PTPIP51, a positive modulator of the MAPK\/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3beta and PTP1B in situ","volume":"26","author":"Petri","year":"2011","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bbrc.2017.12.145_bib28","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.05.045","article-title":"Regulator of calcineurin 1 gene isoform 4, down-regulated in hepatocellular carcinoma, prevents proliferation, migration, and invasive activity of cancer cells and metastasis of orthotopic tumors by inhibiting nuclear translocation of NFAT1","volume":"153","author":"Jin","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2017.12.145_bib29","doi-asserted-by":"crossref","first-page":"21903","DOI":"10.1038\/srep21903","article-title":"Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes","volume":"6","author":"Moirangthem","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2017.12.145_bib30","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.celrep.2016.04.018","article-title":"The lncRNA SLNCR1 mediates melanoma invasion through a conserved SRA1-like region","volume":"15","author":"Schmidt","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.bbrc.2017.12.145_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/j.gastro.2014.12.001","article-title":"Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells","volume":"148","author":"Munakata","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2017.12.145_bib32","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.canlet.2014.09.027","article-title":"Hepatitis C virus NS3 protein enhances cancer cell invasion by activating matrix metalloproteinase-9 and cyclooxygenase-2 through ERK\/p38\/NF-kappaB signal cascade","volume":"356","author":"Lu","year":"2015","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2017.12.145_bib33","doi-asserted-by":"crossref","first-page":"56889","DOI":"10.18632\/oncotarget.10872","article-title":"Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK\/ERK pathway","volume":"7","author":"Lagares-Tena","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2017.12.145_bib34","doi-asserted-by":"crossref","first-page":"40377","DOI":"10.18632\/oncotarget.9750","article-title":"Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1\/2\/MMP9 pathway","volume":"7","author":"Bai","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2017.12.145_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbrc.2016.01.038","article-title":"Cellular prion protein regulates invasion and migration of breast cancer cells through MMP-9 activity","volume":"470","author":"Gil","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17325457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17325457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T02:20:59Z","timestamp":1719714059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17325457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0006291X17325457"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.12.145","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC6 interacts with PTPN1 to enhance melanoma cells progression","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.12.145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}